Transforming growth factor (TGF) b is a potent regulator of cell-matrix and cell-cell adhesions (collectively termed cellular adhesions). Cellular adhesions play crucial roles in controlling the differentiation of epithelial cells and in maintaining the integrity of the epithelium. Loss of TGF b-responsiveness is thought to be an important early initiating event in the malignant progression of epithelial cancer. In the TGFb-responsive human colon adenocarcinoma Moser cells, TGFb promotes cellular adhesions and suppresses their malignant phenotype. TGFb promotes cell-matrix adhesion by inducing the synthesis of extracellular matrix (ECM) adhesion molecules and the expression of integrin receptors for these molecules (termed ECM remodeling). TGFb promotes cell-cell adhesion through the induction of E-cadherin expression, an epithelial associated homotypic cell-cell adhesion molecule, which also functions as a tumor suppressor in colon cancer. How TGFb regulates E-cadherin expression is not known. In this study, we showed that the induction of E-cadherin by TGFb was mediated through the activation of focal adhesion kinase (FAK), a major signaling molecule in focal adhesion contacts and that the activation of FAK was due to ECM remodeling and increased cell-matrix interactions. Thus, TGFb regulates cell-cell adhesion through its ability to remodel the ECM and to activate FAK through ECM remodeling.
Transforming growth factor (TGF) b is a potent regulator of cell-matrix and cell-cell adhesions (collectively termed cellular adhesions). Cellular adhesions play crucial roles in controlling the differentiation of epithelial cells and in maintaining the integrity of the epithelium. Loss of TGF b-responsiveness is thought to be an important early initiating event in the malignant progression of epithelial cancer. In the TGFb-responsive human colon adenocarcinoma Moser cells, TGFb promotes cellular adhesions and suppresses their malignant phenotype. TGFb promotes cell-matrix adhesion by inducing the synthesis of extracellular matrix (ECM) adhesion molecules and the expression of integrin receptors for these molecules (termed ECM remodeling). TGFb promotes cell-cell adhesion through the induction of E-cadherin expression, an epithelial associated homotypic cell-cell adhesion molecule, which also functions as a tumor suppressor in colon cancer. How TGFb regulates E-cadherin expression is not known. In this study, we showed that the induction of E-cadherin by TGFb was mediated through the activation of focal adhesion kinase (FAK), a major signaling molecule in focal adhesion contacts and that the activation of FAK was due to ECM remodeling and increased cell-matrix interactions. Thus, TGFb regulates cell-cell adhesion through its ability to remodel the ECM and to activate FAK through ECM remodeling. Keywords: TGFB; cell adhesion; colon cancer Cell-matrix and cell-cell adhesion (collectively termed cellular adhesions) are fundamental distinguishing features of multicellular organisms and play crucial roles in the maintenance of epithelial integrity (Lin and Bissel, 1993; Roskelley et al., 1994; Shapiro et al., 1995; Gumbiner, 1996) . Proper cellular adhesions and cellular proliferation are linked to normal differentiation of epithelial cells while disruption of such processes is associated with malignant progression (Jacks and Weinberg, 2002) . Transforming growth factor (TGF) b belongs to a large family of multifunctional polypeptides that are intimately involved in regulating the proliferation and differentiation of many cell types (Moses et al., 1990) . In TGFb-responsive human colon adenocarcinoma cells, TGFb induces a more differentiated and less malignant phenotype (Brattain et al., 1984; Chakrabarty et al., 1988 Chakrabarty et al., , 1989 . Loss of TGFb-responsiveness is thought to be an important early initiating event in the malignant progression of colon cancer (Markowitz et al., 1995; Brattain et al., 1996) . TGFb binds to a family of interacting cell-surface receptors to generate the intracellular signals that are required to mediate its biologic function (Wrana et al., 1994) . A hallmark of TGFb action in human colon adenocarcinoma cells is the control of cellular adhesions (Chakrabarty et al., 1988; Chakrabarty, 1992; Rajagopal et al., 1997; Wang and Chakrabarty, 2001 ).
In the TGFb-responsive human colon adenocarcinoma Moser cells, TGFb promotes cell-matrix adhesion (Chakrabarty, 1992) . Increase in cell-matrix adhesion is mediated through the induction of the synthesis and secretion of the extracellular matrix (ECM)-adhesion molecules laminin and fibronectin with a concurrent upregulation of the expression of cell-surface integrin receptors for these ECM-adhesion molecules (Huang and Chakrabarty, 1994; Chakrabarty et al., 1998) , collectively termed ECM remodeling). TGFb regulates ECM remodeling in the Moser cells in a protein kinase C-dependent manner (Chakrabarty and Huang, 1995; Chakrabarty et al., 1998) . Almost concurrently with ECM remodeling, TGFb induces cell-cell adhesion through the induction of E-cadherin expression (Wang and Chakrabarty, 2001) , an epithelial associated homotypic cell-cell adhesion molecule known to have tumorsuppressive function in colon cancer (Breen et al., 1995) . How TGFb control E-cadherin expression is not known. In this study, we showed that the induction of Ecadherin by TGFb was mediated through the activation of focal adhesion kinase (FAK), which was activated by increased cell-matrix interaction as a result of ECM remodeling.
As TGFb increases cell adhesion to the ECM (Chakrabarty, 1992) and cell adhesion to the ECM is mediated by focal adhesion contacts or focal adhesion plaques (Gumbiner, 1996) contact organelles between a cell and the ECM), we hypothesize that TGFb would redistribute cellular adhesion plaque proteins to the focal adhesion contacts. Indeed, an increase in adhesion plaque proteins such as paxillin, vinculin and b1 integrin was readily observed in cell-free focal adhesion plaques that were biochemically isolated from the culture flasks following treatment of the cells with TGFb for 5 h ( Figure 1a ). FAK is a major signal molecule in focal adhesions and is activated by autophosphorylation of tyrosine residues (Schaller et al., 1992; Hanks and Polte, 1997) . TGFb treatment of the cells rapidly induces FAK activation with an almost concurrent stimulation of Ecadherin expression (Figure 1b) . A good induction of Ecadherin was observed 3 h following the activation of FAK (Figure 1b ). The expression of FAK itself, however, was not altered by TGFb (Figure 1c ). In addition, analyses of adhesion plague proteins by immunoprecipitations followed by immunoblottings showed that TGFb stimulated an increase in the interaction and association of these proteins with one another (Figure 1d ). These results strongly suggest that TGFb induction of E-cadherin was mediated through ECM remodeling and FAK activation.
If increased adhesion to the ECM was required for FAK activation and the induction of E-cadherin, then blocking adhesion to the ECM should block the induction of E-cadherin and the activation of FAK. Adhesion to the ECM may be blocked by polyclonal antifibronectin or antilaminin antibodies (Wang and Chakrabarty, 2001 ). Pretreatment of the cells with either polyclonal antifibronectin or antilaminin antibodies before exposure to TGFb effectively blocked the induction of E-cadherin by TGFb (Figure 2a) . Pretreatment of the cells with different concentrations of antilaminin antibodies for 1 h prior to exposure to TGFb blocked the activation of FAK in a dose-dependent manner (Figure 2b ). These results showed that increased cell-matrix interaction as a result of ECM remodeling was required for the activation of FAK and the induction of E-cadherin by TGFb.
In a final series of experiments, we determined if the activation of FAK was required for the induction of Ecadherin by TGFb. Dominant-negative inhibitors of FAK were used to block FAK function. We found that the ability of TGFb to induce E-cadherin was decreased and HA-FAK-Kd (Wary et al., 1998) , (Figure 3a) , while the ability of TGFb to induce E-cadherin was completely blocked in cells stably transfected with the dominant-negative FAK inhibitor FRNK (Lin et al., 1997) , (Figure 3 b,c) . These results showed that the activation of FAK was required for the induction of Ecadherin by TGFb. Next, antisense FAK constructs were then used in transfection experiments to downregulate FAK expression; the consequence of FAK downregulation on the ability of TGFb to induce Ecadherin expression was then determined. FAK expression was found to be down-regulated in cells transfected with the antisense FAK construct and TGFb was unable to induce E-cadherin expression in these cells (Figure 3d ). These experiments demonstrated the important role of FAK in mediating this function of TGFb, that is, the induction of E-cadherin. A hallmark of TGFb action is the control of ECM remodeling. How ECM remodeling is integrated into TGFb function is not understood. TGFb is also known to regulate the expression of E-cadherin (Ilyas et al., 1999; Wang and Chakrabarty, 2001 ). However, the relationship between TGFb-regulated cell-matrix and cell-cell adhesion is not clear. These studies showed that a function of TGFb-mediated ECM remodeling is the activation of FAK and that FAK activation was required for TGFb to induce the expression of E-cadherin. The role of cell-matrix (Thannickal et al., 2003) . It has also been reported that b-catenin expression can be modulated by cell-matrix adhesion (Varallo et al., 2003) . In summary, TGFb regulates cellcell adhesion, in the human colon carcinoma Moser cells, through its ability to remodel the ECM and to activate FAK through ECM remodeling.
